R3 Stem Cell Mexico Delivers Stem Cell Treatments Across Three Advanced Clinics
R3 Stem Cell Mexico is redefining regenerative care through non-surgical stem cell therapies available in Tijuana, Cancún, and Puerto Vallarta. With over 26,000 procedures performed and an 85% satisfaction rate, its clinics are helping patients bypass invasive treatment and regain quality of life through scientifically guided care.
Backed by physician expertise and outcome-driven protocols, R3 Stem Cell Mexico delivers advanced solutions that go beyond symptom management. For patients worn down by medication and conventional care, Stem Cell Mexico offers a direct, science-backed path to recovery rooted in renewal, not routine.
At the heart of R3 Stem Cell Mexico is a clinical approach rooted in transparency, safety, and protocols. Each clinic uses a proprietary mesenchymal stem cell (MSC) product known as Intellicell, considered one of the highest-performing cell products available. Intellicell undergoes rigorous third-party testing to ensure sterility, strength, and viability.
Building on this clinical foundation, stem cell Mexico services include individualized plans centered on umbilical cord-derived MSCs that may integrate exosomes, platelet-rich plasma (PRP), or direct injection therapies. These treatments address a wide range of complex conditions such as orthopedic injuries, neurodegenerative diseases, autoimmune disorders, cardiovascular issues, and aesthetic concerns.
Clinics in Tijuana, Cancún, and Puerto Vallarta offer multiple administration routes, including intravenous infusion, intrathecal injection, nebulized delivery, and topical applications for aesthetic use. These delivery methods preserve cell potency and support treatment plans tailored to each patient's condition and goals.
In addition to offering a wide range of application methods, the R3 Stem Cell team also prioritizes the patient experience through comprehensive medical tourism services. Patients from the U.S. and Canada benefit from streamlined coordination that includes free consultations, bilingual staff, comfortable accommodations, and local transportation. Those pursuing care in Tijuana, Cancún, or Puerto Vallarta receive personalized support from the initial intake through the post-procedure follow-up phase.
To make the entire experience even more accessible, flexible financing options, HSA and FSA eligibility, and price match guarantees are also available. These features help eliminate cost as a barrier to advanced regenerative care.
These patient-first measures underscore the organization's broader commitment to quality and accountability. Every treatment adheres to COFEPRIS regulations, which serve as Mexico's equivalent of the U.S. FDA, with strict safety protocols guiding all procedures. COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) oversees the regulation of biological products and enforces standards for clinical safety, sterility, and manufacturing quality. Although stem cell therapy remains 'experimental' in the U.S., many patients choose the Mexico-based provider for its proven care and global reputation.
R3 Stem Cell Mexico continues to build its standing as a global leader in regenerative medicine, offering innovative care through clinics in three of Mexico's most accessible cities. The organization remains a trusted choice for those seeking proven alternatives to surgery, medication, or conventional care, reinforcing its results-driven reputation.
To learn more about advanced regenerative therapies and clinic locations, visit https://stemcellmexico.com/.
About R3 Stem Cell Mexico
R3 Stem Cell Mexico is a leading regenerative medicine provider operating advanced clinics in Tijuana, Cancún, and Puerto Vallarta. The organization specializes in personalized stem cell therapies using ethically sourced biologics manufactured in certified laboratories. R3's clinical network offers transparent, personalized care with international support, making it a trusted choice for lasting relief and recovery. Its physician-led teams deliver patient-centered treatments backed by outcome tracking, clinical oversight, and uncompromising medical standards.
###
Media Contact
R3 Stem Cell Mexico
Address: David Alfaro Siqueiros 2643-Local 106, Zona Urbana Rio Tijuana, 22010 Tijuana, B.C., Mexico
Phone: (888) 988-0515
Website: https://stemcellmexico.com/
newsroom: news.38digitalmarket.com
Source published by Submit Press Release >> R3 Stem Cell Mexico Delivers Stem Cell Treatments Across Three Advanced Clinics
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
How one small clinic proves hepatitis C doesn't have to be an epidemic
Although it's been over a decade since game-changing curative drugs for hepatitis C were approved, progress has been slow and treatment remains out of reach for many. But one small clinic in Buffalo, New York, is proving that doesn't have to be the case. Hepatitis C is a silent epidemic in the U.S., affecting up to 4 million people, according to the Centers for Disease Control and Prevention. Many people don't know they have it. Left untreated, the disease can cause cirrhosis and liver cancer. With a model that's faster, more accessible and remarkably effective, La Bodega, a clinic at Erie County Medical Center, is curing patients at a staggering rate. One of those patients is Lindsey Groffenberg, who quit drugs and was cured of Hep C at La Bodega. "When you're coming out of addiction, and you're trying to recover, the last thing you want is to feel small," she told CBS News. "When I entered La Bodega, I asked them, 'So, when's the doctor gonna come in?' And he said, 'I am the doctor.'" That doctor was Dr. Tony Martinez. "One of our mottos is 'come one, come all,'" Martinez told CBS News. "It's a very safe, stigma-free space, you know, I think people feel that when they come here." Groffenberg now helps others navigate recovery. Success stories like hers have made the clinic a model program. La Bodega gets Hep C patients on treatment in a single visit, and has a track record of curing about 98% of its 7,000-plus patients. New FDA-approved testing machines help speed up treatment. The testing machines, Martinez explained, allow them to see a patient and in that same visit confirm their diagnosis and initiate their meds. As drug costs have dropped, access should have improved, yet so far, less than a third of Americans with Hep C have been treated. Success stories like La Bodega's have policymakers seeking a national plan to eliminate Hep C. In Washington, a bipartisan bill backed by Senators Bill Cassidy and Chris Van Hollen would invest federal funds into wiping out the disease. The average patient with Hep C can rack up as much as $46,000 a year in medical costs. Treating patients early could save the government an estimated $7 billion over a decade. "This is a monumental step forward for anybody who has Hep C — they'd get access to medications," Martinez. Arkansas officials reveal new details about Devil's Den murders of husband and wife Reporter's Notebook: Diane Arbus' photography legacy Exhibition of influential photographer Diane Arbus' work opens in New York
CBS News
41 minutes ago
- CBS News
Hepatitis C is a silent epidemic in the U.S., but this small clinic is proving it doesn't have to be
Although it's been over a decade since game-changing curative drugs for hepatitis C were approved, progress has been slow and treatment remains out of reach for many. But one small clinic in Buffalo, New York, is proving that doesn't have to be the case. Hepatitis C is a silent epidemic in the U.S., affecting up to 4 million people, according to the Centers for Disease Control and Prevention. Many people don't know they have it. Left untreated, the disease can cause cirrhosis and liver cancer. With a model that's faster, more accessible and remarkably effective, La Bodega, a clinic at Erie County Medical Center, is curing patients at a staggering rate. One of those patients is Lindsey Groffenberg, who quit drugs and was cured of Hep C at La Bodega. "When you're coming out of addiction, and you're trying to recover, the last thing you want is to feel small," she told CBS News. "When I entered La Bodega, I asked them, 'So, when's the doctor gonna come in?' And he said, 'I am the doctor.'" That doctor was Dr. Tony Martinez. "One of our mottos is 'come one, come all,'" Martinez told CBS News. "It's a very safe, stigma-free space, you know, I think people feel that when they come here." Groffenberg now helps others navigate recovery. Success stories like hers have made the clinic a model program. La Bodega gets Hep C patients on treatment in a single visit, and has a track record of curing about 98% of its 7,000-plus patients. New FDA-approved testing machines help speed up treatment. The testing machines, Martinez explained, allow them to see a patient and in that same visit confirm their diagnosis and initiate their meds. As drug costs have dropped, access should have improved, yet so far, less than a third of Americans with Hep C have been treated. Success stories like La Bodega's have policymakers seeking a national plan to eliminate Hep C. In Washington, a bipartisan bill backed by Senators Bill Cassidy and Chris Van Hollen would invest federal funds into wiping out the disease. The average patient with Hep C can rack up as much as $46,000 a year in medical costs. Treating patients early could save the government an estimated $7 billion over a decade. "This is a monumental step forward for anybody who has Hep C — they'd get access to medications," Martinez.
Yahoo
an hour ago
- Yahoo
Clearbridge Health First Half 2025 Earnings: S$0.08 loss per share (vs S$0.004 loss in 1H 2024)
Clearbridge Health (Catalist:1H3) First Half 2025 Results Key Financial Results Revenue: S$4.92m (up 7.1% from 1H 2024). Net loss: S$1.35m (loss narrowed by 42% from 1H 2024). S$0.08 loss per share. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Clearbridge Health shares are down 33% from a week ago. Risk Analysis Before you take the next step you should know about the 5 warning signs for Clearbridge Health (4 are potentially serious!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
